Skip to main content

Table 1 Clinical features of all participants and features according to TyG index quartiles

From: Association between triglyceride-glucose index and low-density lipoprotein particle size in korean obese adults

Variable

Total

(n = 128)

Quartile 1

[7.86– 8.39]

(n = 32)

Quartile 2

(8.41– 8.71)

(n = 32)

Quartile 3

(8.71– 9.08)

(n = 32)

Quartile 4

(9.10– 9.99)

(n = 32)

P-value

Age (years)

44.86 ± 10.07

44.28 ± 10.85

45.64 ± 10.54

46.16 ± 9.89

43.34 ± 9.13

0.674

Sex

     

0.021

 Male

29.0 (22.66%)

2.0 (6.25%)

6.0 (18.75%)

9.0 (28.12%)

12.0 (37.50%)

 

 Female

99.0 (77.34%)

30.0 (93.75%)

26.0 (81.25%)

23.0 (71.88%)

20.0 (62.50%)

 

Body mass index (kg/m²)

30.63 ± 4.95

29.20 ± 4.90

30.81 ± 5.38

31.30 ± 4.70

31.27 ± 4.76

0.300

Waist circumference (cm)

97.44 ± 12.19

92.82 ± 11.14

96.73 ± 14.02

98.21 ± 9.97

102.01 ± 11.94

0.031

Systolic blood pressure (mmHg)

124.24 ± 14.34

121.88 ± 13.34

123.35 ± 15.03

126.19 ± 12.85

125.42 ± 16.20

0.64

Diastolic blood pressure (mmHg)

74.74 ± 10.12

72.80 ± 9.03

74.28 ± 9.49

75.68 ± 8.16

76.13 ± 13.17

0.574

Heart rate (beats/minute)

71.80 ± 10.65

70.87 ± 9.41

74.67 ± 10.96

68.68 ± 11.22

73.03 ± 10.46

0.139

AST (IU/L)

24.00 (11.00–93.00)

22.00 (14.00–46.00)

22.00 (14.00–81.00)

24.50 (15.00–74.00)

27.50 (11.00–93.00)

0.006

ALT (IU/L)

25.00 (4.00–280.00)

18.00 (8.00–64.00)

24.50 (11.00–178.00)

27.00 (4.00–280.00)

30.50 (6.00–231.00)

0.003

GGT (IU/L)

21.50 (7.00–155.00)

12.50 (7.00–30.00)

29.00 (9.00–155.00)

21.50 (10.00–89.00)

26.00 (10.00–141.00)

< 0.001

hsCRP (mg/L)

1.20 (0.10–16.00)

1.00 (0.10–16.00)

1.20 (0.10–15.30)

1.10 (0.20–11.60)

1.20 (0.20–7.70)

0.945

Uric acid (mg/dL)

5.49 ± 1.17

4.99 ± 1.09

5.24 ± 0.93

5.69 ± 1.03

6.06 ± 1.32

< 0.001

Insulin (µU/mL)

10.80 (1.10–45.50)

6.70 (1.10–40.60)

11.00 (3.80–31.60)

9.85 (2.90–30.40)

18.25 (4.50–45.50)

< 0.001

HOMA-IR

49.29 (4.20–223.44)

30.51 (4.20–209.32)

48.11 (14.52–133.42)

47.26 (11.21–137.81)

81.44 (20.40–223.44)

< 0.001

Triglyceride

148.32 ± 83.04

75.84 ± 12.42

104.31 ± 12.37

143.66 ± 17.63

269.47 ± 70.96

< 0.001

Glucose

98.84 ± 9.07

95.78 ± 7.67

98.59 ± 9.10

99.19 ± 8.54

101.81 ± 10.16

0.065

TyG Index

8.77 ± 0.51

8.18 ± 0.17

8.53 ± 0.09

8.86 ± 0.11

9.49 ± 0.26

< 0.001

Abdominal visceral fat area (cm2)

64.30 (25.70–137.00)

56.30 (25.70–105.00)

60.50 (33.40–128.00)

66.70 (40.00–106.00)

69.70 (41.60–137.00)

0.043

Abdominal subcutaneous fat area (cm2)

109.00 (42.60–311.00)

115.00 (42.60–297.00)

95.90 (57.20–201.00)

108.00 (52.80–248.00)

125.50 (43.90–311.00)

0.657

Smoking history

     

0.004

 Yes

12.0 (9.38%)

2.0 (6.25%)

0.0 (0.00%)

2.0 (6.25%)

8.0 (25.00%)

 

 No

116.0 (90.62%)

30.0 (93.75%)

32.0 (100.00%)

30.0 (93.75%)

24.0 (75.00%)

 

Alcohol consumption

     

0.200

 Yes

27.0 (21.09%)

7.0 (21.88%)

3.0 (9.38%)

7.0 (21.88%)

10.0 (31.25%)

 

 No

101.0 (78.91%)

25.0 (78.12%)

29.0 (90.62%)

25.0 (78.12%)

22.0 (68.75%)

 

Hypertension

     

0.924

 Yes

24.0 (33.33%)

6.0 (28.57%)

5.0 (31.25%)

6.0 (37.50%)

7.0 (36.84%)

 

 No

48.0 (66.67%)

15.0 (71.43%)

11.0 (68.75%)

10.0 (62.50%)

12.0 (63.16%)

 

Framingham risk score

3.53 (1.00–18.55)

2.41 (1.00–10.04)

3.09 (1.03–13.05)

4.02 (1.25–13.58)

5.16 (1.40–18.55)

0.011

  1. Values are presented as means ± standard deviations, medians (ranges) or numbers (%)
  2. Abbreviations: AST Aspartate aminotransferase, ALT Alanine aminotransferase, GGT Gamma- glutamyl transferase, hsCRP High-sensitivity C-reactive protein, HOMA-IR Homeostasis model assessment-estimated insulin resistance